Medical device tax: Abiomed's Minogue takes to Capitol Hill to urge repeal

July 25, 2012 by MassDevice staff

Abiomed chairman, president & CEO Mike Minogue testifies before the House of Representatives' Committee on Small Business that the impending 2.3% medical device tax will pose an extra burden on small businesses that "need every dollar to survive."

Abiomed chairman president CEO Mike Minogue

Abiomed (NSDQ:ABMD) chairman, president & CEO Mike Minogue took to Capitol Hill today to testify before the House of Representatives' Committee on Small Business, defending small medical device companies amid the burden they face as the medical device tax nears implementation.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp